Valneva’s Covid-19 Vaccine Reaches UK Market with EU In Sights
A Covid-19 vaccine developed by the French company Valneva has received the green light from…
The Covid-19 pandemic began as a few scattered cases in China, but within months, the respiratory infection had swept the world. The years 2020 and 2021 turned into a rollercoaster ride for the world’s population, with millions of people dead, livelihoods destroyed, and movement between countries plummeting.
Despite the strained situation, academic researchers and biotech and pharma companies globally have come together to develop protective vaccines and treatments against Covid-19. While we still have a long road ahead before this pandemic is declared over, the life sciences industry is bringing us closer to this moment with every new discovery, trial result, and fundraise. Read on to learn about the latest research, investments, trends, and pipeline developments.
European Biotech Industry Report 2021: A Year of European Biotechnology
This report discusses how the Covid-19 pandemic impacted Europe’s life science industry and covers recent market trends, investments, and collaborations in the biotech and pharma industry.
Go to ReportA Covid-19 vaccine developed by the French company Valneva has received the green light from…
The World Health Organization has released a 10-year plan to monitor the genetic make-up of…
In the last two years, Russian Covid-19 vaccine makers had a tough time penetrating the…
Vaccines are among the most effective ways to improve and protect human health. Whereas vaccines…
Despite the widespread rollout of vaccines over 2021, the Covid-19 pandemic remains a threat to…
Thanks to Covid-19 vaccines, messenger RNA (mRNA) technology has reached the mainstream. With a €23.4M…
In spite of the challenges posed by the Covid-19 pandemic, the European biotech industry has…
The EU recently added two drugs to its list of approved Covid-19 treatments. Yet with…
Vaccines for Covid-19 are rolling out all over the world, but their protection is threatened…
Last week, the French vaccine maker Valneva announced promising phase III trial results of its…
CRISPR technology offers the promise to cure any human genetic disease with gene editing; which…
Sanofi’s acquisition of its partner Translate Bio is a clear sign that pharmaceutical companies are…